Track topics on Twitter Track topics that are important to you
Latest release gives enterprise clients access to real-time data to improve reporting and decision-making for outsourced R&D investments
Demonstrating the company’s commitment to support its clients’ growth plans by optimizing data aggregation and business intelligence, Science Exchange, the world’s leading and most secure platform for outsourced research and development (R&D), recently released the latest version of its enterprise dynamic report tool. The tool enables Science Exchange’s enterprise clients, including some of the world’s top pharma and biotech companies, to perform real-time tracking of key performance indicators (KPIs) related to their outsourced R&D investments.
"The Science Exchange enterprise dynamic report gives me the ability to tease out diverse suppliers and export spend data. Our procurement management team has been thrilled with the report," said Greg Smith, Associate Director, Indirect R&D Procurement, Teva Pharmaceuticals Industries, Ltd.
This latest enterprise dynamic report update allows enterprise clients like Teva Pharmaceuticals Industries, Ltd., to:
“With this dynamic reporting tool, our enterprise clients are able to gain a whole new understanding of category-specific purchasing behaviors within their organizations. R&D and procurement leaders can receive and proactively analyze – in real time – data and business intelligence that can help them quickly assess the performance and impact of their outsourced R&D programs, ” said Elizabeth Iorns, Ph.D., co-founder and CEO of Science Exchange. “Science Exchange helps our clients make data-driven business decisions, while at the same time giving researchers quick and secure access to more than 2,500 scientific service providers – allowing researchers to focus on innovation and discovery.”
About Science Exchange
Science Exchange is the world's leading platform for outsourced research, providing an efficient procure-to-pay platform for ordering services from a network of more than 2,500 qualified scientific service providers, all with pre-established contracts in place that protect client intellectual property and confidentiality. The platform increases scientists' access to innovation and improves productivity, freeing them up from the administrative tasks and delays associated with sourcing, establishing and managing service provider contracts. Additionally, the Science Exchange enterprise program enables organizations to consolidate research R&D outsourcing spend into a single strategic relationship, driving efficiency and cost savings. Since being founded in 2011, Science Exchange has raised more than $58 million from Norwest Venture Partners, Maverick Capital Ventures, Union Square Ventures, Collaborative Fund, Index Ventures, OATV, the YC Continuity Fund, and others. For more information, visit www.ScienceExchange.com; follow the company on Twitter @ScienceExchange.
Big Swing Communications
Kerry Metzdorf, 978-463-2575
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...